Piramal Healthcare UK is a finished-dose manufacturer based in United Kingdom. It holds 2 active US drug master files and one valid CEP across a filed portfolio of 2 molecules. Its filings concentrate with MINSA (CR), EDE (AE) and NAFDAC (NG). Its GMP standing is certified by MHRA (UK), NAFDAC (NG) and US FDA, among 4 authorities. Its most recent recorded inspection, by US FDA, closed on 30 May 2025 as NAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Morpeth, United Arab Emirates | Not on file |
| Canada, Canada | 3002808377 |
| GRANGEMOUTH, United Kingdom | Not on file |
| Morpeth, United Kingdom | Not on file |
| NORTHUMBERLAND, United Kingdom | Not on file |
| United Kingdom, United Kingdom | 3003723155 |
2 further sites are on record.
| Molecule | Regulators | Docs |
|---|---|---|
| Misoprostol | EDQM, US FDA | 2 |
| Cloprostenol | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MINSA (CR) | 5 | None |
| EDE (AE) | 5 | None |
| NAFDAC (NG) | 3 | 2 |
| NPRA (MY) | 1 | None |
| MCAZ (ZW) | 1 | None |
| ARCSA (EC) | 1 | None |
| MHRA (UK) | None | 12 |
| US FDA | None | 1 |
| NCELS (KZ) | None | 1 |
Choose your molecules and target markets. Piramal Healthcare UK comes back tiered against every other supplier able to file there.
Start for free